Sali, Lapo http://orcid.org/0000-0002-3366-1660
Ventura, Leonardo
Grazzini, Grazia
Borgheresi, Alessandra
Delsanto, Silvia
Falchini, Massimo
Mallardi, Beatrice
Mantellini, Paola
Milani, Stefano
Pallanti, Stefano
Zappa, Marco
Mascalchi, Mario
Funding for this research was provided by:
Regione Toscana (POR CREO FESR 1.1c)
Ente Cassa di Risparmio di Firenze (2012.0742A2202.3931)
Article History
Received: 18 July 2018
Revised: 10 September 2018
Accepted: 27 September 2018
First Online: 6 November 2018
Compliance with ethical standards
:
: The scientific guarantor of this publication is Professor Mario Mascalchi.
: One author of this manuscript (Silvia Delsanto) declares relationships with the following company: Im3D, Turin, Italy.All other authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: One of the authors has significant statistical expertise.
: Written informed consent was obtained from all subjects in this study.
: Institutional Review Board approval was obtained.
: Socio-demographic characteristics of the SAVE trial invitees and participants, as well as participation rate and detection rate for advanced neoplasia after the first screening round, were previously reported in Sali L, Mascalchi M, Falchini M, et al Reduced and full-preparation CT colonography, fecal immunochemical test, and colonoscopy for population screening of colorectal cancer: a randomized trial. <i>J Natl Cancer Inst</i> 2015;108: 319.
: • Prospective• Randomised controlled trial• Performed at one institution